RegBlog

RegBlog

Healthcare

There is More to Mandatory Disclosure than Meets the Eye

Oct 27, 2014 Opinion

"Targeted transparency" can help achieve regulatory and regulated entity goals.

Tagged: , , , , ,

Interstate Medical Licensure and Emergency Response

Oct 20, 2014 Opinion

Adoption of new model legislation could improve medical response to public health crises and disasters.

Tagged: , , , , ,

Inflating Civil Penalties

Apr 2, 2014 News

FDA adjusts maximum civil money penalties to account for inflation.

Tagged: , , ,

What is the Future for Genetic Testing and Personalized Medicine?

Feb 6, 2014 Analysis

FDA declares personalized medicine “has clearly arrived.”

Tagged: , ,

A New Tax-and-Spend Strategy to Fight Obesity

Jan 6, 2014 Analysis

Scholar proposes a manufacturers’ excise tax to fund obesity-prevention efforts.

Tagged: , , , , ,

FDA Moves to Address Drug Shortages

Nov 19, 2013 News

Agency hopes a strategic plan and proposed rule will protect patients from delayed treatment.

Tagged: ,

House Bill Would Limit FDA Oversight of Health Apps

Nov 18, 2013 Analysis

Supporters of legislation argue FDA will not cabin its regulatory power on its own.

Tagged: , ,

Taking Targeted Immunity Statutes Seriously

Sep 16, 2013 Opinion

Recent Supreme Court rulings provide insight into variable tort litigation outcomes.

Tagged: , , ,

Inside Baseball: The Nature of OIRA’s Work

Sep 11, 2013 Opinion

The regulatory review process engages a wide range of actors.

Tagged: , , , , ,

State Powers Remain Vital After the ACA Decision

Sep 3, 2013 Opinion

State governments still have great power to negotiate favorable outcomes.

Tagged: ,